Title : Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphoma patients.

Pub. Date : 2015 Mar

PMID : 24519501






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphoma patients. pirarubicin caspase recruitment domain family member 16 Homo sapiens
2 All patients received six cycles of biweekly THP-COP. pirarubicin caspase recruitment domain family member 16 Homo sapiens
3 Biweekly THP-COP is a safe and promising therapy for patients with newly diagnosed PTCL. pirarubicin caspase recruitment domain family member 16 Homo sapiens